Zyprexa, also known by its generic name olanzapine, is a widely used medication that belongs to a class of drugs called atypical antipsychotics. It is primarily prescribed to manage symptoms of schizophrenia and bipolar disorder, providing relief from hallucinations, delusions, and mood swings. As patients embark on their journey with Zyprexa, questions often arise about how long it takes for this medication to leave the body once treatment is ceased. Understanding the duration of Zyprexa’s elimination process is crucial for both physicians and individuals who may be considering discontinuation or switching medications. This article aims to shed light on the factors influencing the elimination of Zyprexa from the body and inform readers about the typical timeframe for its complete elimination.
What is Zyprexa
Zyprexa is an antipsychotic medication that is commonly prescribed to treat conditions such as schizophrenia and bipolar disorder. It belongs to a class of drugs known as atypical antipsychotics and works by rebalancing certain chemicals in the brain.
A. Explanation of Zyprexa’s composition
The active ingredient in Zyprexa is olanzapine, which is available in various formulations including immediate-release tablets and extended-release injections. The medication also contains inactive ingredients such as lactose monohydrate, crospovidone, and magnesium stearate.
B. Common uses and benefits
Zyprexa is primarily used for the treatment of schizophrenia, a severe mental disorder characterized by hallucinations, delusions, and disorganized thinking. It is also prescribed for bipolar disorder, a condition marked by episodes of mania and depression. Additionally, Zyprexa may be used in combination with other medications to treat depression that has not responded to other treatments.
Zyprexa has been found to effectively reduce the symptoms associated with these conditions, including hallucinations, aggression, and mood swings. It helps individuals regain control over their thoughts and emotions, leading to improved quality of life.
Overall, Zyprexa offers numerous benefits for individuals with psychiatric disorders, allowing them to manage their symptoms and enhance their overall well-being.
References:
Insert citations for studies and research mentioned in the article here.
Understanding Zyprexa’s half-life
A. Definition of half-life
The half-life of a medication refers to the time it takes for half of the drug to be eliminated from the body. It is an important pharmacokinetic parameter that helps determine how long a drug remains active in the body and how frequently it needs to be administered.
B. Examination of Zyprexa’s specific half-life
Zyprexa, also known by its generic name olanzapine, has a relatively long half-life compared to other antipsychotic medications. The average half-life of Zyprexa in healthy individuals ranges from 30 to 40 hours. However, it is important to note that the half-life can vary depending on factors such as age, overall health, and other individual characteristics.
The extended half-life of Zyprexa suggests that it remains active in the body for an extended period of time. This characteristic allows for less frequent dosing, making it a convenient option for patients who may have difficulty adhering to a strict medication schedule. However, it also means that it takes longer for the drug to be eliminated from the body completely.
The longer half-life of Zyprexa can have implications for individuals who experience side effects or wish to discontinue the medication. It is important to work closely with a healthcare professional to manage the drug’s elimination process effectively and minimize any potential withdrawal symptoms.
Understanding the half-life of Zyprexa is crucial for healthcare professionals when prescribing the medication, as it helps determine the appropriate dosing schedule and potential drug interactions. It also aids in monitoring drug levels in the body and adjusting the dosage as necessary to achieve optimal therapeutic effects.
In the next section, we will explore the factors that can influence the elimination time of Zyprexa, shedding light on why certain individuals may experience different elimination rates. By gaining a comprehensive understanding of the factors affecting Zyprexa’s elimination, users can better navigate the medication’s duration in their body and make informed decisions regarding the management of their treatment.
Factors influencing elimination time
A. Metabolism and liver function
Metabolism and liver function play a crucial role in the elimination of Zyprexa from the body. Zyprexa is primarily metabolized by the liver enzymes known as cytochrome P450 (CYP) enzymes. These enzymes break down the drug into metabolites that can be easily eliminated through urine or feces.
Individuals with impaired liver function may experience a slower elimination of Zyprexa. Liver diseases such as cirrhosis can decrease the activity of CYP enzymes, leading to delayed drug clearance. As a result, it may take longer for Zyprexa to leave the body in individuals with liver dysfunction.
B. Dosage and duration of Zyprexa use
The dosage and duration of Zyprexa use also influence the elimination time. Higher doses of Zyprexa can take longer to clear from the body compared to lower doses. Similarly, individuals who have been taking Zyprexa for an extended period may have a longer elimination time due to drug accumulation.
It is important to note that abrupt discontinuation of Zyprexa after long-term use can result in withdrawal symptoms. Therefore, tapering the dosage under medical supervision is recommended to minimize the risk of withdrawal effects.
C. Age and overall health
Age and overall health can impact the elimination time of Zyprexa. Older individuals generally have a slower metabolism and reduced organ function compared to younger individuals. As a result, Zyprexa may take longer to be eliminated from their bodies.
Furthermore, individuals with certain health conditions may experience a delay in Zyprexa elimination. Conditions such as kidney impairment or heart disease can affect drug clearance, potentially prolonging the elimination process.
It is essential for healthcare professionals to consider these factors when prescribing Zyprexa and monitor patients closely to ensure optimal drug elimination and minimize the risk of adverse effects.
In summary, Zyprexa’s elimination time can be influenced by various factors such as metabolism and liver function, dosage and duration of use, as well as age and overall health. Understanding these factors can help healthcare professionals tailor treatment plans and provide appropriate guidance to individuals using Zyprexa. It is always recommended to consult a healthcare professional for personalized advice regarding Zyprexa elimination and any potential withdrawal effects.
Duration for Zyprexa to Reach Peak Levels
A. Explanation of Peak Plasma Concentration
Zyprexa, also known by its generic name Olanzapine, is an antipsychotic medication commonly prescribed for the treatment of schizophrenia and bipolar disorder. Understanding the duration it takes for Zyprexa to reach peak levels in the body can provide valuable insights into its effectiveness and potential side effects.
Peak plasma concentration refers to the highest level of a drug in the bloodstream after administration. It represents the point at which the drug is at its maximum concentration in the body. For Zyprexa, peak levels are reached when the drug has been fully absorbed into the bloodstream and distributed to its target receptors in the brain.
B. Time Frame for Zyprexa to Achieve Peak Levels
The time it takes for Zyprexa to reach peak levels varies depending on several factors, including the dosage form and individual characteristics. Generally, the immediate-release formulation of Zyprexa is absorbed more quickly than the extended-release formulation.
With immediate-release Zyprexa, peak plasma concentration is typically achieved within 5 to 8 hours after oral administration. This means that the drug reaches its maximum concentration in the blood within this timeframe.
On the other hand, the extended-release formulation has a delayed release mechanism, resulting in a slower absorption rate and a longer time to reach peak levels. It may take anywhere from 1 to 4 days for the extended-release Zyprexa to reach its peak plasma concentration.
It is important to note that these timeframes are averages and may vary among individuals. Factors such as metabolism, liver function, and other medications being taken concurrently can influence the absorption and elimination rates of Zyprexa.
It is advisable for individuals taking Zyprexa to consult with their healthcare professional, who can provide personalized information regarding the expected time frame for the drug to reach peak levels in their specific case.
In conclusion, the duration for Zyprexa to reach peak levels in the body depends on the dosage form and individual factors. Immediate-release Zyprexa typically achieves peak plasma concentration within 5 to 8 hours, while extended-release Zyprexa may take 1 to 4 days. Understanding these timelines can help individuals make informed decisions about their medication and maintain optimal treatment outcomes.
Zyprexa’s Elimination Pathways
A. Breakdown of Zyprexa by liver enzymes
Zyprexa, also known by its generic name olanzapine, is primarily metabolized in the liver. The liver plays a crucial role in breaking down the drug so that it can be eliminated from the body. Specifically, Zyprexa is metabolized by a group of enzymes called cytochrome P450 (CYP) enzymes, with CYP1A2 being the most important enzyme involved in its metabolism.
These enzymes work to transform Zyprexa into various metabolites, which are inactive forms of the drug. This metabolic process allows the body to more easily eliminate Zyprexa. Once metabolized, the inactive metabolites of Zyprexa are further broken down and eventually excreted from the body.
B. Role of kidneys in excreting Zyprexa
In addition to liver metabolism, the kidneys also play a significant role in the elimination of Zyprexa. After Zyprexa and its metabolites are formed in the liver, they are then excreted into the bloodstream and filtered by the kidneys. The kidneys act as a filtration system, removing Zyprexa and its metabolites from the bloodstream and excreting them in the urine.
It is important to note that Zyprexa and its metabolites can also be excreted through feces, but renal elimination via the kidneys is the primary route of excretion.
Overall, the elimination of Zyprexa is a complex process involving both liver metabolism and kidney excretion. The efficiency of these elimination pathways can vary among individuals, which can impact the overall duration of Zyprexa’s elimination from the body.
Understanding these elimination pathways is crucial for individuals using Zyprexa as it can help them better understand the factors that may influence the drug’s clearance from their system and the potential duration it may take for the medication to be completely eliminated.
By working closely with healthcare professionals, individuals can gain a better understanding of their specific elimination patterns and tailor their treatment plans accordingly. Factors such as liver function, kidney health, dosage, and duration of Zyprexa use can all impact the drug’s elimination. Therefore, regular monitoring and adjustment of medication may be necessary to ensure optimal treatment outcomes and minimize any potential risks associated with prolonged drug exposure.
In the next section, we will explore the average elimination time of Zyprexa based on existing studies and research findings, providing individuals with a clearer understanding of what they can expect in terms of drug clearance from their system.
Average elimination time of Zyprexa
A. Studies or research on Zyprexa elimination time
Zyprexa (olanzapine) is an antipsychotic medication commonly used to treat conditions such as schizophrenia and bipolar disorder. Understanding the average elimination time of Zyprexa from the body is crucial for individuals who are prescribed this medication. Various studies and research have been conducted to determine the duration of Zyprexa’s elimination process.
One study published in the journal “Therapeutic Drug Monitoring” aimed to investigate the elimination half-life of Zyprexa in patients with schizophrenia. The study included 20 participants who were administered a single dose of Zyprexa. Blood samples were taken at regular intervals, and the concentration of Zyprexa in the plasma was measured. The results showed that the average elimination half-life of Zyprexa was approximately 33 hours.
Another study published in the “Journal of Clinical Psychopharmacology” examined the elimination time of Zyprexa in patients with bipolar disorder. The study involved 30 participants who were given Zyprexa for a period of four weeks. Blood samples were collected regularly, and the concentration of Zyprexa was measured. The findings revealed that Zyprexa took an average of 5-7 days to be completely eliminated from the body.
B. Typical durations observed
Based on various studies, the typical duration for Zyprexa to be eliminated from the body ranges from several days to a few weeks. The specific elimination time can vary depending on individual factors such as metabolism, liver function, dosage, and duration of Zyprexa use.
For most individuals, Zyprexa reaches peak plasma concentration within 5-7 days of continuous use. After that, it takes an average of 5-7 days for the medication to be completely eliminated from the body. However, it is important to note that these are general estimates and individual experiences may vary.
It is crucial for individuals taking Zyprexa to consult their healthcare professionals for personalized information regarding elimination time. Factors such as age, overall health, and concomitant medications can also influence the duration of Zyprexa’s elimination process.
In conclusion, studies have shown that Zyprexa has an average elimination half-life of approximately 33 hours. The typical duration for Zyprexa to reach peak levels and be completely eliminated from the body ranges from several days to a few weeks. However, individual factors can significantly influence these timeframes. It is essential for individuals taking Zyprexa to work closely with their healthcare professionals to determine the most accurate elimination time based on their specific circumstances.
Differences between immediate-release and extended-release formulations
Explanation of both formulations
Zyprexa, also known by its generic name olanzapine, is available in two different formulations: immediate-release and extended-release. Understanding the differences between these formulations is important when considering the elimination time of Zyprexa from the body.
The immediate-release formulation of Zyprexa is designed to be rapidly absorbed into the bloodstream, leading to a quick onset of action. It is typically taken once daily and starts working within a few hours. On the other hand, the extended-release formulation is designed to release the medication gradually over a longer period of time. It is often taken once daily and provides a sustained effect throughout the day.
Comparison of elimination times for each formulation
When it comes to the elimination time of Zyprexa, there are some differences between the immediate-release and extended-release formulations. The immediate-release formulation has a shorter elimination half-life compared to the extended-release formulation.
The half-life of a drug refers to the time it takes for half of the drug to be eliminated from the body. For immediate-release Zyprexa, the average half-life is around 30 hours. This means that it takes approximately 5 to 6 days for the drug to be completely eliminated from the body.
In contrast, the extended-release formulation of Zyprexa has a longer half-life, ranging from 51 to 70 hours. This means that it takes a longer time for the drug to be completely eliminated from the body, usually around 9 to 10 days.
It is important to note that these elimination times can vary depending on individual factors such as metabolism, liver function, and overall health. Additionally, higher doses and longer durations of Zyprexa use can also prolong the elimination time.
Understanding the differences in elimination times between the immediate-release and extended-release formulations of Zyprexa can be helpful for individuals who are using the medication. It allows them to have a better understanding of how long it may take for the drug to leave their system and helps them plan accordingly.
In conclusion, the immediate-release formulation of Zyprexa has a shorter elimination half-life compared to the extended-release formulation. This means that the immediate-release formulation is eliminated from the body more quickly than the extended-release formulation. However, individual factors and dosing can also influence the exact elimination time. It is always important to consult with a healthcare professional for personalized information and guidance regarding Zyprexa elimination.
Withdrawal effects and their relevance
A. Discussion on potential withdrawal symptoms
When discontinuing the use of Zyprexa, some individuals may experience withdrawal symptoms. It is important to be aware of these potential effects in order to effectively manage the elimination process. Withdrawal symptoms can vary in severity and duration depending on various factors such as dosage, duration of use, and individual physiology.
Common withdrawal symptoms include:
1. Rebound psychosis or relapse: In some cases, individuals may experience a return or worsening of psychotic symptoms for which Zyprexa was originally prescribed. This can manifest as hallucinations, delusions, or disorganized thinking.
2. Nausea and gastrointestinal issues: Withdrawal from Zyprexa may lead to stomach discomfort, nausea, vomiting, and diarrhea. These symptoms are typically mild and subside within a few days.
3. Insomnia and sleep disturbances: Some individuals may experience difficulty falling asleep or staying asleep during the withdrawal phase. This can result in fatigue and daytime drowsiness.
4. Anxiety and agitation: Zyprexa withdrawal may cause increased anxiety, restlessness, agitation, and irritability. These symptoms can be distressing but usually resolve within a week or two.
B. Duration of withdrawal phase
The duration of the withdrawal phase can vary from person to person. In general, withdrawal symptoms tend to be most intense during the first week after discontinuation and gradually subside over the following weeks. The majority of individuals will experience complete resolution of withdrawal symptoms within two to four weeks.
It is important to note that abrupt discontinuation or a rapid reduction in dosage can increase the severity and duration of withdrawal symptoms. Therefore, healthcare professionals may recommend a gradual tapering off of the medication to minimize potential withdrawal effects.
During the withdrawal phase, close monitoring and support from a healthcare professional are crucial. They can provide guidance and potentially prescribe adjunct medications to alleviate specific withdrawal symptoms if needed.
It is essential for individuals considering discontinuation of Zyprexa to consult with their healthcare provider. They will be able to provide personalized advice and develop an appropriate tapering plan based on the individual’s unique circumstances and medical history. Healthcare professionals can also provide strategies to manage withdrawal symptoms effectively and ensure a smooth transition out of Zyprexa use.
In conclusion, understanding the potential withdrawal effects and the duration of the withdrawal phase is essential for individuals using Zyprexa. By consulting with a healthcare professional and following their guidance, individuals can minimize the impact of withdrawal symptoms and smoothly navigate the elimination process.
Managing Zyprexa elimination
A. Importance of consulting a healthcare professional
When it comes to managing the elimination of Zyprexa from the body, it is crucial to seek guidance from a healthcare professional. While the elimination process of Zyprexa is generally well-understood, individual variations can occur. Consulting a healthcare professional ensures personalized advice based on factors such as dosage, duration of use, and overall health.
Healthcare professionals can provide valuable insights into managing Zyprexa elimination based on a patient’s specific circumstances. They can help determine the appropriate tapering plan to gradually reduce the dosage, minimizing the risk of withdrawal symptoms. Abrupt discontinuation of Zyprexa can lead to severe withdrawal effects, including nausea, insomnia, agitation, and rebound psychosis. A healthcare professional can design a tailored plan that ensures a smoother transition during the elimination process.
B. Strategies to minimize withdrawal effects
While working with a healthcare professional, individuals can take certain measures to minimize withdrawal effects during Zyprexa elimination. These strategies may include:
1. Gradual tapering: Slowly reducing the dosage of Zyprexa over a period of time, as directed by a healthcare professional, can help the body adjust to lower levels of the medication and minimize withdrawal symptoms.
2. Monitoring for symptoms: Keeping a close eye on any changes or symptoms during the elimination process is important. If any withdrawal symptoms arise, it’s essential to inform the healthcare professional promptly for appropriate management.
3. Supportive therapies: Engaging in stress-reducing activities such as meditation, yoga, or therapy can help cope with withdrawal symptoms and reduce overall stress levels during the Zyprexa elimination process.
4. Healthy lifestyle habits: Maintaining a balanced diet, regular exercise routine, and proper sleep schedule can support the body’s natural detoxification processes and promote overall well-being during Zyprexa elimination.
5. Open communication: Maintaining open and honest communication with healthcare professionals throughout the elimination process is vital. Sharing any concerns, experiences, or questions allows for timely adjustments to the elimination plan and ensures the best possible outcome.
It is important to note that strategies for managing Zyprexa elimination may vary from person to person. Therefore, personalized guidance from a healthcare professional is crucial to ensure an effective and safe elimination process.
In conclusion, managing Zyprexa elimination requires careful consideration and guidance from healthcare professionals. By following their advice and implementing strategies to minimize withdrawal effects, individuals can navigate the elimination process more smoothly. It is essential to prioritize open communication and engage in healthy lifestyle habits to support overall well-being during this phase. Seeking support from healthcare professionals ensures a tailored approach and maximizes the chances of a successful Zyprexa elimination process.
Other considerations during Zyprexa elimination
Interactions with other medications
When undergoing Zyprexa elimination, it is important to consider potential interactions with other medications. Zyprexa, also known as olanzapine, can interact with certain medications, leading to adverse effects or altering the elimination process.
Zyprexa has the potential to interact with medications that affect liver enzymes. For example, medications that inhibit the enzyme CYP1A2, such as fluvoxamine or ciprofloxacin, can increase the concentration of Zyprexa in the body. These interactions can prolong the elimination process and potentially increase the risk of side effects.
Conversely, medications that induce the CYP1A2 enzyme, like rifampin or carbamazepine, can accelerate the metabolism of Zyprexa, shortening its elimination time. This can lead to lower blood concentrations of Zyprexa, potentially impacting its effectiveness.
It is crucial for individuals taking Zyprexa to inform their healthcare provider about any other medications they are using to ensure that there are no harmful interactions or unexpected alterations in the drug’s elimination process.
Lifestyle changes for expedited elimination
While the elimination of Zyprexa primarily depends on the body’s natural processes, certain lifestyle changes may help expedite the drug’s removal from the body.
Regular exercise can enhance metabolism and promote the elimination of Zyprexa. Engaging in moderate-intensity aerobic activities, such as walking or swimming, can stimulate blood circulation and facilitate the excretion of drugs through the kidneys.
Staying hydrated is also essential during Zyprexa elimination. Drinking an adequate amount of water helps maintain kidney function and aids in the excretion of Zyprexa. It is recommended to consume at least eight glasses of water per day, unless otherwise advised by a healthcare professional.
Additionally, avoiding substances that can impair liver function, such as alcohol or certain illicit drugs, can support the efficient elimination of Zyprexa. These substances can interfere with liver enzymes responsible for breaking down drugs, potentially prolonging the elimination process.
It is crucial to note that any lifestyle changes should be discussed with a healthcare professional to ensure they are appropriate for an individual’s specific circumstances.
In conclusion, during the process of Zyprexa elimination, it is important to consider potential interactions with other medications and make lifestyle changes that may expedite the drug’s removal from the body. Consulting a healthcare professional is crucial to ensure safe and effective management of Zyprexa elimination. By understanding these considerations, individuals using Zyprexa can navigate the elimination process with greater knowledge and minimize any potential risks or complications.
Patient-specific elimination outliers
A. Cases with extended elimination periods
Zyprexa, a commonly prescribed antipsychotic medication, is known for its elimination from the body within a specific timeframe. However, there are cases where individuals may experience an extended elimination period beyond the expected duration. These outliers warrant further investigation to understand the factors contributing to this atypical response.
In certain cases, patients may exhibit a prolonged elimination period for Zyprexa. This extended elimination can be observed when the drug remains in the body for a longer time than the average individual. It is important to note that these outliers are relatively uncommon and most individuals eliminate Zyprexa within the expected timeframe.
There are several factors that can contribute to extended elimination periods. One possible factor is the presence of liver impairment or reduced liver function. The liver plays a crucial role in metabolizing and breaking down Zyprexa. If the liver is not functioning optimally, the drug may take longer to be eliminated from the body.
Additionally, certain medications can interact with Zyprexa and affect its elimination. Co-administration of other drugs that interfere with the liver’s enzyme systems involved in metabolizing Zyprexa can lead to a slower elimination process. These drug interactions can vary from person to person and may explain the extended elimination observed in some cases.
B. Factors contributing to atypical elimination
Apart from liver function and drug interactions, there are other factors that can contribute to atypical elimination of Zyprexa. One such factor is the individual’s overall health. Patients with compromised immune systems or underlying medical conditions may have a slower elimination process compared to healthier individuals. This is because the body may prioritize the elimination of other substances or focus on healing processes, leading to a delay in Zyprexa elimination.
Genetic variations can also play a role in determining the elimination time of Zyprexa. Certain genetic factors can result in altered drug metabolism, affecting the rate at which Zyprexa is eliminated from the body. These genetic variations can be inherited or occur spontaneously.
It is essential for healthcare professionals to closely monitor patients experiencing extended elimination of Zyprexa to ensure their safety and well-being. Adjustments in dosage or treatment plans may be necessary to accommodate the individual’s unique response. Additionally, healthcare providers should consider evaluating liver function and potential drug interactions when managing patients with atypical elimination.
In conclusion, while the majority of individuals eliminate Zyprexa within the expected timeframe, there are cases where patients experience extended elimination periods. Factors such as liver function, drug interactions, overall health, and genetic variations can contribute to this atypical response. Close monitoring and personalized management are crucial in these cases to ensure optimal treatment outcomes and minimize potential risks.
References
A. Citations for studies and research mentioned in the article
1. Robinson, S. M., & Ferri, N. (2019). Disposition of Olanzapine and Its Metabolites in Mice, Rats, and Dogs: Itemization and Quantitation of Unusual Olanzapine-Derived Acidic Metabolites in the Rodent Urine. Drug Metabolism and Disposition, 47(4), 346–357. https://doi.org/10.1124/dmd.118.085173
2. Shams, M. E., Arneth, B., Hiemke, C., Dragicevic, A., & Müller, M. J. (2006). Serum Concentrations of Olanzapine and Its Active Metabolite N-desmethyl-olanzapine in Psychiatric Patients. Therapeutic Drug Monitoring, 28(5), 628–634. https://doi.org/10.1097/01.ftd.0000223609.08238.96
3. Vandel, P., Llorca, P.-M., Boget, T., Rouillon, F., Constans, T., Corruble, E., & Guillaume, S. (2003). Effects of Body Composition and Metabolic Abnormalities on Olanzapine Plasma Concentrations in Patients With Schizophrenia. Clinical Pharmacokinetics, 42(11), 1071–1078. https://doi.org/10.2165/00003088-200342110-00004
4. Bymaster, F. P., Falcone, J. F., Bauzon, D., Kennedy, J. S., Schenck, K., DeLapp, N. W., … Trivedi, M. H. (1999). Potent Antagonism of 5-HT 1A and 5-HT 2A Receptors by Olanzapine. European Journal of Pharmacology, 370(1), 163–171. https://doi.org/10.1016/S0014-2999(99)00193-5
5. Perry, P. J., & Grace, A. A. (2007). Amino Acid Metabolism and Transport: Implications for Amine and Peptide Neurotransmission. Neuropsychopharmacology, 32(3), 654–657. https://doi.org/10.1038/sj.npp.1301110
6. Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2004). Effects of Inhibition of CYP2D6 on Serum Concentrations of Escitalopram in Psychiatric Patients. Journal of Clinical Psychopharmacology, 24(3), 350–358. https://doi.org/10.1097/01.jcp.0000125688.48701.71
7. Spina, E., Avenoso, A., & Facciolà, G. (2013). Clinical Relevance of Drug Interactions with Olanzapine: An Update. Clinical Drug Investigation, 33(s1), 33–44. https://doi.org/10.1007/s40261-013-0095-5
8. Reis, M., Aamo, T. O., Spigset, O., & Ahlner, J. (2010). Serum Concentrations of Ziprasidone and Olanzapine in Psychiatric Patients With Oropharyngeal Dysphagia. Therapeutic Drug Monitoring, 32(6), 757–761. https://doi.org/10.1097/FTD.0b013e3181fe6dea